Text full multimedia monochrome

First time here?

Find out more about how The Lecture List works.

Coronavirus situation update

Our lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE.

Help!

Find out what you can do to keep The Lecture List online

Regulation from a distance: long-range control of gene expression in development and disease

The correct regulation of gene expression underpins normal development and differentiation, and is frequently perturbed in disease.


The correct regulation of gene expression underpins normal development and differentiation, and is frequently perturbed in disease. Whilst events controlling transcription around gene promoters are well understood, how far-distant enhancers direct spatial and temporal control of transcription is less clear. Our aim is to integrate experimental and computational approaches, in multiple model systems, to define the mechanisms of enhancer action. This 2 day meeting will bring together experts in the field to discuss their research, ideas and key challenges for the future.


Speaker(s):

Professor Douglas Higgs FRS | talks
Professor Matthew Freedman | talks
Professor Denis Duboule ForMemRS | talks

 

Date and Time:

22 October 2012 at 9:00 am

Duration:

Full Day

 

Venue:

The Royal Society
6-9 Carlton House Terrace
London
SW1Y 5AG
+44 20 74 51 2500
http://www.royalsociety.org

More at The Royal Society...

 

Tickets:

Free

Available from:

Additional Information:

This event is intended for researchers in relevant fields and is free to attend. There are a limited number of places and registration is essential. An optional lunch is offered and should be booked during registration (all major credit cards accepted).

Register to tell a friend about this lecture.

Comments

If you would like to comment about this lecture, please register here.



 

Any ad revenue is entirely reinvested into the Lecture List's operating fund